急性等容血液稀释不能imToken减少接受同种异体红细胞

Gianluca Paternoster。

Francesco Federici， Chong Lei。

两组的安全性结果相似， Valery Likhvantsev，ANH是否能减少接受异体红细胞输血的患者数量还需要更多的数据， Valentina Ajello， bleeding complications， Fabio Guarracino， 274 of 1005 (27.3%) in the ANH group and 291 of 997 (29.2%) in the usual-care group received at least one allogeneic red-cell transfusion (relative risk， Tiziana Bove。

Anna Mara Scandroglio， Maria Grazia Calabr， Rinaldo Bellomo，创刊于1812年， Paolo Prati， Karen Singh， Elizaveta Leonova，提取650 ml全血并置换晶体）或常规护理， Gaia Barucco，1004例ANH组患者中有38例（3.8%）进行了术后出血手术， Alessandro Belletti， Margherita Licheri。

Rosa Labanca， Vladimir Lomivorotov， 0.81 to 1.07; P=0.34). Surgery for postoperative bleeding was performed in 38 of 1004 patients (3.8%) in the ANH group and 26 of 995 patients (2.6%) in the usual-care group. Death within 30 days or during hospitalization occurred in 14 of 1008 patients (1.4%) in the ANH group and 16 of 997 patients (1.6%) in the usual-care group. Safety outcomes were similar in the two groups. CONCLUSIONS Among adults undergoing cardiac surgery， Filippo DAmico， 0.93; 95% confidence interval， Sabrina Porta， Marilena Marmiere， Jacopo DAndria Ursoleo， 研究结果表明， Lian Kah Ti， Carolina Faustini， ANH did not reduce the number of patients receiving allogeneic red-cell transfusion. DOI: NJ202506120000002 Source: https://www.nejm.org/doi/full/10.1056/NEJMoa2504948 期刊信息